(Q37384720)

20 August 2017

Active assessment of adverse events following yellow fever vaccination of persons aged 60 years and more (English)

1 reference

20 August 2017

0 references

1 reference

Karina Takesaki Miyaji

1

1 reference

20 August 2017

André Machado Luiz

2

1 reference

20 August 2017

Amanda Nazareth Lara

3

1 reference

20 August 2017

Tania do Socorro Souza Chaves

4

1 reference

20 August 2017

Roberta de Oliveira Piorelli

5

1 reference

20 August 2017

Marta Heloisa Lopes

6

1 reference

20 August 2017

Ana Marli Christovam Sartori

7

1 reference

20 August 2017

4 January 2013

1 reference

Human Vaccines & Immunotherapeutics

20 August 2017

1 reference

20 August 2017

9

1 reference

20 August 2017

2

1 reference

20 August 2017

277-282

1 reference

Immunization site pain: case definition and guidelines for collection, analysis, and presentation of immunization safety data

20 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3859747

The safety of yellow fever vaccine 17D or 17DD in children, pregnant women, HIV+ individuals, and older persons: systematic review

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3859747

Elderly subjects have a delayed antibody response and prolonged viraemia following yellow fever vaccination: a prospective controlled cohort study

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3859747

Diarrhea: case definition and guidelines for collection, analysis, and presentation of immunization safety data

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3859747

Suspected yellow fever vaccine-associated viscerotropic adverse events (1973 and 1978), United States

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3859747

Yellow fever vaccine - how does it work and why do rare cases of serious adverse events take place?

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3859747

A local reaction at or near injection site: case definition and guidelines for collection, analysis, and presentation of immunization safety data

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3859747

Adverse event reports following yellow fever vaccination

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3859747

Fatigue: case definition and guidelines for collection, analysis, and presentation of immunization safety data

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3859747

Fever as an adverse event following immunization: case definition and guidelines of data collection, analysis, and presentation

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3859747

Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3859747

Serious adverse events associated with yellow fever 17DD vaccine in Brazil: a report of two cases

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3859747

Dynamic behavior of sylvatic yellow fever in Brazil (1954-2008).

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3859747

Monitoring adverse events following yellow fever vaccination using an integrated telephone and Internet-based system

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3859747

Yellow fever 17D vaccine safety and immunogenicity in the elderly.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3859747

Reactogenicity of yellow fever vaccines in a randomized, placebo-controlled trial

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3859747

Yellow fever vaccine. WHO position paper

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3859747

Yellow Fever Vaccine Post-marketing Surveillance in Brazil

14 September 2017

1 reference

Crossref

https://api.crossref.org/works/10.4161%2FHV.22714

21 January 2018

Identifiers

DOI

10.4161/HV.22714

1 reference

20 August 2017

1 reference

20 August 2017

PubMed publication ID

23291944

1 reference